| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* Department of Biomedical Engineering, Rutgers University, Piscataway, New Jersey 08854;
Laboratory of Protein Dynamics and Signaling, National Cancer Institute, Frederick, Maryland;
Department of Neurosurgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania;
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland; ¶ Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland; and || Research Services, Baltimore VA Medical Center, Baltimore, Maryland
Correspondence: Address reprint requests to N. N. Boustany, PhD, Dept. of Biomedical Engineering, Rutgers University, 617 Bowser Rd., Piscataway, NJ 08854. Tel.: 732-445-5337; Fax: 732-445-3753; E-mail: nboustan{at}rci.rutgers.edu.
We measured the intensity ratio of wide-to-narrow angle scatter, optical scatter image ratio (OSIR), in single cells during apoptosis and after overexpression of the mitochondria-bound antiapoptotic protein BCL-xL. OSIR is sensitive to particle size/shape for objects with wavelength-scale dimensions, and was used as a morphometric measure of cellular response. Three cell variants were treated with staurosporine (STS): nontransfected parental CSM14.1, CSM14.1 stably expressing yellow fluorescent protein (YFP) with diffuse YFP fluorescence, and apoptosis-resistant CSM14.1 stably expressing the fusion protein construct YFP-BCL-xL with YFP fluorescence localized on the mitochondria. After treatment with 1 or 2 µM STS, the measured OSIR decreased monotonically by
25% in the nontransfected and YFP variants, and reached a steady-state value 4060 min after STS treatment. The decrease in OSIR at the onset of apoptosis preceded phosphatidyl serine exposure by 5 h. In the YFP-BCL-xL cell variant, the initial OSIR was already
24% lower than the initial OSIR in YFP and nontransfected cells, and only decreased by <10% after STS treatment. Alterations in light scattering by cells overexpressing BCL-xL even before apoptosis induction raise interesting questions as to the role of BCL-xL in conferring apoptosis resistance by preconditioning the cells and possibly altering mitochondrial morphology.
This article has been cited by other articles:
![]() |
J.-Y. Zheng, Y.-C. Tsai, P. Kadimcherla, R. Zhang, J. Shi, G. A. Oyler, and N. N. Boustany The C-Terminal Transmembrane Domain of Bcl-xL Mediates Changes in Mitochondrial Morphology Biophys. J., January 1, 2008; 94(1): 286 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Wilson, C. E. Bigelow, D. J. Calkins, and T. H. Foster Light Scattering from Intact Cells Reports Oxidative-Stress-Induced Mitochondrial Swelling Biophys. J., April 1, 2005; 88(4): 2929 - 2938. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |